Search
for
Sort by
Research 211–240 of 1000+
- Sexual health in rheumatology
- Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury
- Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome
- The Conception and Evaluation of Sexual Health Literature
- Persistent Sexual Side Effects of Finasteride: Could They Be Permanent?
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- HPA Axis Variation and ACEs; Childhood Sexual Trauma is Associated with Lower Hair Cortisol in Adulthood
- Letter to the Editor: “Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss”
- Sexual desire in a sample of married Egyptian women with polycystic ovarian syndrome
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Sexual Medicine Reviews—The Premiere Review Journal for the Field of Sexual Medicine
- Sexual difference, identification and object choice in individuals with sex differentiation disorders
- Sexual Dimorphism in Micronutrient Homeostasis and Cluster Depletion Patterns in Type 2 Diabetes Mellitus Patients with Hair Loss: Development and Validation of a Phenotype-Based Risk Stratification Tool
- Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review
- Finasteride. dutasteride risk of suicide and sexual dysfunction
- Psychological Well-Being and Sexual Functioning Before and After Hair Transplantation: A Longitudinal Clinical Study of 40 Patients at Vera Clinic
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- An (Ir)reversible Affection of the Sexual Sphere: A Case Report
- Finasteride- versus dutasteride-related sexual AEs
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- Evaluation of Sexual Dysfunctions in Male Patients with Androgenetic Alopecia
- Psychiatric and sexual dysfunction warnings strengthened for finasteride and dutasteride
- 0885 The androgen-THY1 axis mediates sexual dimorphism in dermal adipogenesis and fibrosis
- Sexual dysfunction in chronic diseases: How does technology help treat and manage sexual dysfunction in chronic patients?
- Sexual transmission of a new emerging dermatophyte: <i>T. Mentagrophytes</i> genotype VII
- Sexual dysfunction with 5-alpha-reductase inhibitor therapy for androgenetic alopecia: a global propensity score matched retrospective cohort study
- 175 Reinventing the Selfie: Telemedicine in a Tertiary Referral Sexual Medicine Practice
- Effect of 5α-reductase inhibitors on sexual function: New contributions
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs